Peer-reviewedCC BYCurrent issues in molecular biology
Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review
- 1Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania; (D.C.); (C.V.)
- 2Department VII, Internal Medicine II, Discipline of Cardiology, , E. Murgu Square, Nr. 2, 300041 Timisoara, Romania
Related
- Dynamic remodeling of the KRAS interactome by direct RAS inhibitors with distinct mechanism of action reveals convergent responses
- Association between neuromuscular electrical stimulation and intermittent pneumatic compression for the prevention of deep venous thrombosis among neurosurgery patients
- Continuous versus intermittent endotracheal tube cuff pressure control for the prevention of ventilator-associated pneumonia: A focused systematic review and exploratory meta-analysis.
- SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis
- RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis
BibTeX
@article{cozma2026metformin,
title = {{Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review}},
author = {Dragos Cozma and Cristina Tudoran and Cristina Vacarescu},
journal = {Current issues in molecular biology},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13703335},
note = {CC BY},
}
RIS
TY - JOUR
TI - Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review
AU - Dragos Cozma
AU - Cristina Tudoran
AU - Cristina Vacarescu
PY - 2026
DA - 2026/09/30
JO - Current issues in molecular biology
UR - https://europepmc.org/article/PMC/PMC13703335
SN - 1467-3037
SN - 1467-3045
ER -